IRAG1
Inositol 1,4,5-triphosphate receptor associated 1
Also known as: IRAG, IRAG1_HUMAN, JAW1L, MRVI1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y6F6
- Gene
- IRAG1
- Ensembl
- ENSG00000072952
- Chromosome
- 11
- Canonical length
- 904 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nuclear bodies,Cytosol
OverviewNCBI Gene
This gene is similar to a putative mouse tumor suppressor gene (Mrvi1) that is frequently disrupted by mouse AIDS-related virus (MRV). The encoded protein, which is found in the membrane of the endoplasmic reticulum, is similar to Jaw1, a lymphoid-restricted protein whose expression is down-regulated during lymphoid differentiation. This protein is a substrate of cGMP-dependent kinase-1 (PKG1) that can function as a regulator of IP3-induced calcium release. Studies in mouse suggest that MRV integration at Mrvi1 induces myeloid leukemia by altering the expression of a gene important for myeloid cell growth and/or differentiation, and thus this gene may function as a myeloid leukemia tumor suppressor gene. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene, and alternative translation start sites, including a non-AUG (CUG) start site, are used. [provided by RefSeq, May 2011]
Canonical amino-acid sequenceUniProt
904 residues, UniProt reviewed canonical sequence.
>Q9Y6F6|IRAG1
1 MGMDLTCPFG ISPACGAQAS WSIFGADAAE VPGTRGHSQQ EAAMPHIPED EEPPGEPQAA
61 QSPAGQGPPA AGVSCSPTPT IVLTGDATSP EGETDKNLAN RVHSPHKRLS HRHLKVSTAS
121 LTSVDPAGHI IDLVNDQLPD ISISEEDKKK NLALLEEAKL VSERFLTRRG RKSRSSPGDS
181 PSAVSPNLSP SASPTSSRSN SLTVPTPPGL DVCSGPPSPL PGAPPQQKGD EADVSSPHPG
241 EPNVPKGLAD RKQNDQRKVS QGRLAPRPPP VEKSKEIAIE QKENFDPLQY PETTPKGLAP
301 VTNSSGKMAL NSPQPGPVES ELGKQLLKTG WEGSPLPRSP TQDAAGVGPP ASQGRGPAGE
361 PMGPEAGSKA ELPPTVSRPP LLRGLSWDSG PEEPGPRLQK VLAKLPLAEE EKRFAGKAGG
421 KLAKAPGLKD FQIQVQPVRM QKLTKLREEH ILMRNQNLVG LKLPDLSEAA EQEKGLPSEL
481 SPAIEEEESK SGLDVMPNIS DVLLRKLRVH RSLPGSAPPL TEKEVENVFV QLSLAFRNDS
541 YTLESRINQA ERERNLTEEN TEKELENFKA SITSSASLWH HCEHRETYQK LLEDIAVLHR
601 LAARLSSRAE VVGAVRQEKR MSKATEVMMQ YVENLKRTYE KDHAELMEFK KLANQNSSRS
661 CGPSEDGVPR TARSMSLTLG KNMPRRRVSV AVVPKFNALN LPGQTPSSSS IPSLPALSES
721 PNGKGSLPVT SALPALLENG KTNGDPDCEA SAPALTLSCL EELSQETKAR MEEEAYSKGF
781 QEGLKKTKEL QDLKEEEEEQ KSESPEEPEE VEETEEEEKG PRSSKLEELV HFLQVMYPKL
841 CQHWQVIWMM AAVMLVLTVV LGLYNSYNSC AEQADGPLGR STCSAAQRDS WWSSGLQHEQ
901 PTEQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IRAG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 162 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 162 nTPM
- smooth muscle: 65 nTPM
- colon: 64 nTPM
- cervix: 57 nTPM
- endometrium: 54 nTPM
- fallopian tube: 50 nTPM
Single-cell type
- astrocytes: 183 nCPM
- vascular smooth muscle cells: 161 nCPM
- pericytes: 105 nCPM
- smooth muscle cells: 64 nCPM
- peritubular myoid cells: 46 nCPM
- bergmann glia: 38 nCPM
Immune cell
- neutrophil: 24 nTPM
- non-classical monocyte: 5.7 nTPM
- intermediate monocyte: 3.9 nTPM
- classical monocyte: 2.2 nTPM
- eosinophil: 1.7 nTPM
- naive B-cell: 0.9 nTPM
Brain region
- thalamus: 166 nTPM
- basal ganglia: 152 nTPM
- midbrain: 126 nTPM
- medulla oblongata: 114 nTPM
- amygdala: 109 nTPM
- spinal cord: 91 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.63
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IRAG1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IRAG1 as an antibody target. Whether an autoantibody or antibody against IRAG1 could matter depends on whether native IRAG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IRAG1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IRAG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...